Company profile for ProQR Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are ProQR, a company on a mission to create new medicines for patients in need. We focus on a group of diseases called rare diseases, with a very high need for new medicines. Out of the approximately 7,000 rare diseases, less than 400 have a treatment, and we intend to change that. To treat these diseases we use RNA therapies, a technology that allows us to address inherited diseases that are caused by a genetic defect.Our ...
We are ProQR, a company on a mission to create new medicines for patients in need. We focus on a group of diseases called rare diseases, with a very high need for new medicines. Out of the approximately 7,000 rare diseases, less than 400 have a treatment, and we intend to change that. To treat these diseases we use RNA therapies, a technology that allows us to address inherited diseases that are caused by a genetic defect.Our focus is on diseases that are very severe and have limited treatment options.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Zernikedreef 9 Leiden, Zuid-Holland 2333CK, NL
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3196934/33039/en/ProQR-to-Participate-in-8th-Annual-Evercore-Healthcare-Conference.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/10/20/3169294/33039/en/ProQR-Receives-CTA-Authorization-for-AX-0810-and-Announces-Virtual-Investor-and-Analyst-Event-on-November-3-2025.html

GLOBENEWSWIRE
20 Oct 2025

https://www.globenewswire.com/news-release/2025/10/13/3165541/33039/en/ProQR-to-Participate-in-Upcoming-Investor-Conferences-in-October-2025.html

GLOBENEWSWIRE
13 Oct 2025

https://www.globenewswire.com/news-release/2025/08/07/3129058/33039/en/ProQR-Announces-Second-Quarter-2025-Operating-and-Financial-Results.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/07/28/3122441/33039/en/ProQR-Announces-Upcoming-Presentation-at-RNA-Editing-Summit.html

GLOBENEWSWIRE
28 Jul 2025

https://www.globenewswire.com/news-release/2025/06/26/3106239/33039/en/ProQR-Announces-CTA-Submission-for-Phase-1-Study-of-AX-0810-Targeting-NTCP.html

GLOBENEWSWIRE
26 Jun 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty